Sciton Joule System for Pigmentation Disorders
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new combination of treatments for pigmentation issues such as sunspots or discoloration. It examines the effectiveness of Broad-Based Light (BBL), MOXI, and HALO treatments (part of the Sciton Joule System) in improving skin appearance. Participants will receive either one or two treatment sessions spaced a few weeks apart. The trial seeks healthy adults with lighter skin tones (Fitzpatrick types 1-4) who might benefit from skin resurfacing and are willing to avoid other cosmetic treatments during the study. As an unphased trial, it offers a unique opportunity to explore innovative treatment combinations for enhancing skin appearance.
Do I have to stop taking my current medications for the trial?
The trial requires stopping certain medications before participating. You must stop using Accutane or systemic retinoids 6 weeks prior, topical retinoids 4 weeks prior, and certain skin lightening medications 4 months prior. Additionally, you should not use antiplatelet agents, anticoagulants, or psychiatric drugs that impair understanding of the study.
What prior data suggests that the Sciton Joule System is safe for treating pigmentation disorders?
Research has shown that the combination of Broad Based Light (BBL), MOXI, and HALO treatments is generally well-tolerated. Studies have found that BBL treatments are safe, with most individuals experiencing only mild side effects like redness or temporary darkening of the skin. These effects usually resolve quickly, allowing individuals to resume normal activities soon after treatment.
Using these treatments together addresses various skin issues, such as pigmentation and texture. While individual experiences can vary, other studies have found these treatments safe for many patients. It is important to consult a doctor about any concerns before starting treatment to ensure it is the right choice.12345Why are researchers excited about this trial?
Researchers are excited about the Sciton Joule System for pigmentation disorders because it combines three innovative technologies: Broad Based Light (BBL), Fractionated 1927 (MOXI), and Dual Wavelength 2940/1470 (HALO). Unlike standard treatments like topical creams or chemical peels, this combination targets both surface and deeper skin layers, potentially offering more comprehensive results. The dual wavelength feature of HALO allows precise targeting of pigmentation while minimizing downtime, making it a promising option for those seeking faster recovery and enhanced skin tone improvement. This multi-faceted approach could provide more effective and longer-lasting results than existing methods.
What evidence suggests that the Sciton Joule System is effective for pigmentation disorders?
This trial will compare the effectiveness of single versus double treatments using the combination of Broad Based Light (BBL), MOXI, and HALO for pigmentation disorders. Research has shown that combining these treatments can help with skin pigmentation problems. Specifically, studies indicate that the 1927 nm laser in MOXI improves sun damage, such as sunspots and uneven skin tone. BBL uses light energy to warm the skin and encourage natural healing, aiding pigment issues. HALO employs two types of light to enhance skin texture and pigmentation. Together, these treatments have shown promise in addressing pigmentation and texture issues, suggesting effectiveness for pigmentation disorders.36789
Who Is on the Research Team?
Jeffrey Kenkel, MD
Principal Investigator
UT Southwestern
Are You a Good Fit for This Trial?
This trial is for adults aged 20-75 with Fitzpatrick skin types 1-4 who could benefit from skin resurfacing. Participants must avoid other aesthetic treatments during the study, agree to a pregnancy test if applicable, and use effective birth control.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 1-2 BBL/MOXI/HALO treatments, with the second treatment scheduled 4-8 weeks after the initial treatment
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 1 Month and 3 Months post final treatment
What Are the Treatments Tested in This Trial?
Interventions
- Combining Broad Based Light (BBL), Fractionated 1927 (MOXI) and Dual Wavelength 2940/1470 (HALO)
Trial Overview
The Sciton Joule System is being tested on up to 15 subjects at UT Southwestern Medical Center. This non-randomized study involves up to two treatments combining BBL (Broad Based Light), MOXI (Fractionated 1927), and HALO (Dual Wavelength 2940/1470) for pigmentation disorders.
How Is the Trial Designed?
2
Treatment groups
Active Control
Subjects will receive double treatment of BBL/MOXI/HALO 4-6 weeks apart.
Subjects will receive a single treatment of BBL/MOXI/HALO
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Texas Southwestern Medical Center
Lead Sponsor
Sciton
Industry Sponsor
Citations
Combining Broad Based Light (BBL), Fractionated 1927 ...
Combining Broad Based Light, Fractionated 1927 and Dual Wavelength 2940/1470 for Diffuse Pigmentation, Texture and Actinic Changes ... Skin Pigmentation Disorders ...
2.
clinicaltrials.gov
clinicaltrials.gov/study/NCT06091215?term=AREA%5BBasicSearch%5D(AREA%5BBasicSearch%5D(and%201927))&rank=6Combining Broad Based Light (BBL), Fractionated 1927 ...
Combining Broad Based Light, Fractionated 1927 and Dual Wavelength 2940/1470 for Diffuse Pigmentation, Texture and Actinic Changes. Conditions. Pigment Skin.
Investigating the efficacy of a fractionated 1927 nm laser for ...
These results demonstrate that fractionated, nonablative 1927 nm laser treatment is an effective modality for improving clinical and subclinical photodamage.
4.
researchgate.net
researchgate.net/publication/369473836_Investigating_the_efficacy_of_a_fractionated_1927_nm_laser_for_diffuse_dyspigmentation_and_actinic_changes(PDF) Investigating the efficacy of a fractionated 1927 nm ...
The purpose of this study was to quantify the magnitude and duration of actinic pigment and photodamage response in patients of Fitzpatrick Skin ...
5.
aging.networkofcare.org
aging.networkofcare.org/riverside/CommunityResources/ClinicalTrials/Detail/NCT06091215?keyword=%22Pigment%20Skin%22Combining Broad Based Light (BBL), Fractionated 1927 ...
Subjects will receive 1-2 BBL/MOXI/HALO treatments. All 2nd treatments will be scheduled 4-8 weeks after the initial treatment to ensure the skin has enough ...
Safety and Efficacy of Broad Band Light In Motion Treatment
It identifies the role of the intervention that participants receive. Types of arms include experimental arm, active comparator arm, placebo comparator arm, ...
A Novel Combination of BroadBand Light (BBL® HEROTM ...
Follow-up time was variable; in one patient, a marked reduction in hyperpigmentation was observed almost 20 months post-treatment. The results presented in this ...
Effectiveness of combination therapy of broadband light ...
Our results show that BBL not only effectively reduced the pigmentation, but also the vascularization. As for the vessel clearance, long-pulsed ...
9.
drdarrenmckeown.com
drdarrenmckeown.com/treatments/bbl-treatment/answerpack/bbl-broadband-light-treatment/what-are-the-risks-of-bbl-laser-treatment/What are the risks of BBL laser treatment?
BBL treatments at McKeown Medical are safe and involve minimal downtime. While some redness or darkening of pigmentation may occur, most patients resume daily ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.